A Meta-Analysis of the Effect of PCSK9-Monoclonal Antibodies on Circulating Lipoprotein (a) Levels

被引：0
|
作者：
Ye-Xuan Cao
Hui-Hui Liu
Sha Li
Jian-Jun Li
机构：
[1] Peking Union Medical College,Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences
来源：
American Journal of Cardiovascular Drugs | 2019年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：87 / 97
页数：10
相关论文
共 50 条
  • [1] A Meta-Analysis of the Effect of PCSK9-Monoclonal Antibodies on Circulating Lipoprotein (a) Levels
    Cao, Ye-Xuan
    Liu, Hui-Hui
    Li, Sha
    Li, Jian-Jun
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (01) : 87 - 97
  • [2] Impact of PCSK9 monoclonal antibodies on circulating hs-CRP levels: a systematic review and meta-analysis of randomised controlled trials
    Cao, Ye-Xuan
    Li, Sha
    Liu, Hui-Hui
    Li, Jian-Jun
    BMJ OPEN, 2018, 8 (09):
  • [3] Therapeutic efficacy and safety of PCSK9-monoclonal antibodies on familial hypercholesterolemia and statin-intolerant patients: A meta-analysis of 15 randomized controlled trials
    Li Jun Qian
    Yao Gao
    Yan Mei Zhang
    Ming Chu
    Jing Yao
    Di Xu
    Scientific Reports, 7
  • [4] Therapeutic efficacy and safety of PCSK9-monoclonal antibodies on familial hypercholesterolemia and statin-intolerant patients: A meta-analysis of 15 randomized controlled trials
    Qian, Li Jun
    Gao, Yao
    Zhang, Yan Mei
    Chu, Ming
    Yao, Jing
    Xu, Di
    SCIENTIFIC REPORTS, 2017, 7
  • [5] META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS EVALUATING THE EFFECT OF PCSK9 INHIBITORS ON LIPOPROTEIN(A) LEVELS
    Xie, S.
    Galimberti, F.
    Olmastroni, E.
    Catapano, A.
    Casula, M.
    ATHEROSCLEROSIS, 2023, 379
  • [6] The Effect of Bariatric Surgery on Circulating Levels of Lipoprotein (a): A Meta-analysis
    Jamialahmadi, Tannaz
    Reiner, Zeljko
    Alidadi, Mona
    Kroh, Matthew
    Almahmeed, Wael
    Ruscica, Massimiliano
    Sirtori, Cesare
    Rizzo, Manfredi
    Santos, Raul D. D.
    Sahebkar, Amirhossein
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [7] The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodies
    Lambert, Gilles
    Thedrez, Aurelie
    Croyal, Mikael
    Ramin-Mangata, Stephane
    Couret, David
    Diotel, Nicolas
    Nobecourt-Dupuy, Estelle
    Krempf, Michel
    LeBail, Jean Christophe
    Poirier, Bruno
    Blankenstein, Jorg
    Villard, Elise F.
    Guillot, Etienne
    CLINICAL SCIENCE, 2017, 131 (04) : 261 - 268
  • [8] BINDING OF PCSK9 TO CIRCULATING LDL: EFFECT OF PCSK9 MONOCLONAL ANTIBODIES ON THE LDL-BOUND PCSK9?
    De Stefano, D.
    Baragetti, A.
    Baragetti, A.
    Macri, N.
    Tavori, H.
    Fazio, S.
    Catapano, A. L.
    ATHEROSCLEROSIS, 2018, 275 : E101 - E101
  • [9] Latest clinical evidence about the effect of PCSK9 monoclonal antibodies in patients with familial hypercholesterolaemia: an updated meta-analysis
    Zhang, Qiongfang
    Deng, Lianxiang
    Chen, Cong
    Pan, Xu
    Jiang, Shan
    ENDOKRYNOLOGIA POLSKA, 2022, 73 (01) : 110 - 120
  • [10] The effect of bariatric surgery on circulating levels of lipoprotein(a): a systematic review and meta-analysis
    Jamialahmadi, T.
    Reiner, Z.
    Alidadi, M.
    Kroh, M.
    Almahmeed, W.
    Ruscica, M.
    Sirtori, C.
    Santos, R. D.
    Banach, M.
    Sahebkar, A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2366 - 2366
12345